Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies
- PMID: 28522039
- DOI: 10.1016/j.jaad.2016.11.012
Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies
Abstract
The use of neuromodulators for therapeutic and cosmetic indications has proven to be remarkably safe. While aesthetic and functional adverse events are uncommon, each anatomic region has its own set of risks of which the physician and patient must be aware before treatment. The therapeutic usages of botulinum toxins now include multiple specialties and multiple indications. New aesthetic indications have also developed, and there has been an increased utilization of combination therapies to combat the effects of global aging. In the second article in this continuing medical education series, we review the prevention and treatment of adverse events, therapeutic and novel aesthetic indications, controversies, and a brief overview of combination therapies.
Keywords: abobotulinum; adverse events; botulinum toxin; controversies; cosmetic uses; incobotulinum; neuromodulator; neurotoxin; onabotulinum; therapeutic uses.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Injectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents.J Am Acad Dermatol. 2017 Jun;76(6):1013-1024. doi: 10.1016/j.jaad.2016.11.022. J Am Acad Dermatol. 2017. PMID: 28522038 Review.
-
The Use of Neurotoxins in the Male Face.Dermatol Clin. 2018 Jan;36(1):29-42. doi: 10.1016/j.det.2017.09.005. Dermatol Clin. 2018. PMID: 29108543 Review.
-
Injection technique in neurotoxins and fillers: Indications, products, and outcomes.J Am Acad Dermatol. 2018 Sep;79(3):423-435. doi: 10.1016/j.jaad.2018.01.037. J Am Acad Dermatol. 2018. PMID: 30119866 Review.
-
Men's aesthetic dermatology.Semin Cutan Med Surg. 2014 Dec;33(4):188-97. doi: 10.12788/j.sder.0113. Semin Cutan Med Surg. 2014. PMID: 25830252 Review.
-
S1 guideline aesthetic botulinum toxin therapy.J Dtsch Dermatol Ges. 2013 Oct;11(10):e1-13. doi: 10.1111/ddg.12195. J Dtsch Dermatol Ges. 2013. PMID: 26227365 No abstract available.
Cited by
-
Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.Toxins (Basel). 2017 Dec 28;10(1):18. doi: 10.3390/toxins10010018. Toxins (Basel). 2017. PMID: 29283397 Free PMC article. Review.
-
Causes of Botulinum Toxin Treatment Failure.Clin Cosmet Investig Dermatol. 2022 Jun 7;15:1045-1049. doi: 10.2147/CCID.S363321. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35698547 Free PMC article. Review.
-
Developing Consensus-Based Guidelines for Case Reporting in Aesthetic Medicine: Enhancing Transparency and Standardization.Aesthet Surg J Open Forum. 2023 Aug 18;5:ojad076. doi: 10.1093/asjof/ojad076. eCollection 2023. Aesthet Surg J Open Forum. 2023. PMID: 37694226 Free PMC article.
-
Adverse effects of the aesthetic use of botulinum toxin and dermal fillers on the face: a narrative review.An Bras Dermatol. 2025 Jan-Feb;100(1):87-103. doi: 10.1016/j.abd.2024.04.007. Epub 2024 Nov 29. An Bras Dermatol. 2025. PMID: 39616095 Free PMC article. Review.
-
AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.Toxins (Basel). 2018 Dec 13;10(12):535. doi: 10.3390/toxins10120535. Toxins (Basel). 2018. PMID: 30551641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical